# Banco Santander, S.A.: financial statements, quarterly

SAN · NYSE · CIK 891478 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/san.md) · [Financials](/companies/san/financials.md) · [Filings](/companies/san/filings.md) · [Insiders](/companies/san/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/san/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | period not labelled (2022-08-31) | FY2022 (2022-12-31) | period not labelled (2023-08-31) | FY2023 (2023-12-31) | period not labelled (2024-08-31) | FY2024 (2024-12-31) | period not labelled (2025-08-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [114](/filings/0000891478-22-000044.md) | [101](/filings/0000891478-23-000047.md) | [154](/filings/0000891478-24-000038.md) | [211](/filings/0000891478-25-000054.md) | [131](/filings/0000891478-23-000047.md) | [223](/filings/0000891478-25-000054.md) | [107](/filings/0000891478-24-000038.md) | [220](/filings/0000891478-26-000030.md) | [87.8](/filings/0000891478-25-000054.md) | [192](/filings/0000891478-26-000030.md) | [96.9](/filings/0000891478-26-000030.md) | [152](/filings/0000891478-26-000030.md) |
| Total assets | $bn | [1,459](/filings/0000891478-21-000041.md) | [1,523](/filings/0000891478-22-000044.md) | [1,508](/filings/0000891478-23-000047.md) | [1,596](/filings/0000891478-24-000038.md) | not reported | [1,735](/filings/0000891478-25-000054.md) | not reported | [1,797](/filings/0000891478-26-000030.md) | not reported | [1,837](/filings/0000891478-26-000030.md) | not reported | [1,868](/filings/0000891478-26-000030.md) |
| Total liabilities | $bn | [1,352](/filings/0000891478-21-000041.md) | [1,412](/filings/0000891478-22-000044.md) | [1,417](/filings/0000891478-23-000047.md) | [1,499](/filings/0000891478-24-000038.md) | not reported | [1,637](/filings/0000891478-25-000054.md) | not reported | [1,693](/filings/0000891478-26-000030.md) | not reported | [1,730](/filings/0000891478-26-000030.md) | not reported | [1,755](/filings/0000891478-26-000030.md) |
| Shareholders' equity | $bn | [119](/filings/0000891478-20-000017.md) | [122](/filings/0000891478-20-000017.md) | [91.3](/filings/0000891478-24-000038.md) | [97.1](/filings/0000891478-25-000054.md) | not reported | [97.6](/filings/0000891478-26-000030.md) | not reported | [104](/filings/0000891478-26-000030.md) | not reported | [107](/filings/0000891478-26-000030.md) | not reported | [113](/filings/0000891478-26-000030.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:EquityAttributableToOwnersOfParent, ifrs-full:Equity

Shares outstanding: 14,689,319,502 at 2025-12-31, from the cover of the [20-F filed 2026-02-27](/filings/0000891478-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.